|| Objective: To survey the current status and problems of cooperation between clinics and hospitals in Okayama Prefecture, Japan for the treatment of rheumatoid arthritis (RA).
Methods: We distributed a questionnaire to 300 of the 983 Okayama Prefecture clinics that had either an internal medicine or orthopedic surgery department, from December 2013 to February 2014. The questionnaire covered practice pattern for RA treatment in clinics, current status of the hospital and clinic cooperation, and acceptance of the biologic therapy.
Results: One hundred clinics responded to the questionnaire. Seventy percent of the clinics reported making referrals to rheumatologists before the initiation of RA treatment, and half of the other 30% of the clinics administered methotrexate as the first-line treatment for RA by their own decision. Sixty-six clinics cooperated with flagship hospitals, conducting medical and laboratory examinations, providing prescriptions, and treating common diseases of patients. These clinics expected the cooperating rheumatologists to follow-up patients every 3 to 6 months and to make the diagnosis, make decisions regarding RA treatment changes, and perform surgery. Seventy-one percent of the clinics responded that cooperation with a hospital is possible even for patients who are administered biologics. As reasons for no cooperation with the flagship hospitals, clinics noted the lack of information about rheumatologists in the area and recent trends in the management of RA.
Conclusion: The current study reported, for the first time, the actual conditions of management of RA in clinics, as well as future problems of hospital and clinic cooperation in Okayama Prefecture.
|| 1) Kosinski M, Kujawski SC, Martin R, Wanke LA, Buatti MC, Ware JE Jr, Perfetto EM : Health-related quality of life in early rheumatoid arthritis : impact of disease and treatment response. AJMC (2002) 8, 231-240.
2) Scire CA, Lunt M, Marshall T, Symmons DP, Verstappen SM : Early remission is associated with improved survival in patients with inflammatory polyarthritis : results from the Norfolk Arthritis Register. Ann Rheum Dis (2014) 73, 1677-1682.
3) Aga AB, Lie E, Uhlig T, Olsen IC, Wierod A, Kalstad S, Rodevand E, Mikkelsen K, Kvien TK, Haavardsholm EA : Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade : results from the NOR-DMARD study 2000-2010. Ann Rheum Dis (2013). doi : 10.1136/annrheumdis-2013-204020.
4) Smolen JS, Landewe R, Breedveld FC, Buch M, Burmester G, Dougados M, Emery P, Gaujoux-Viala C, Gossec L, Nam J, Ramiro S, Winthrop K, et al. : EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs : 2013 update. Ann Rheum Dis (2014) 73, 492-509.
5) 山崎 秀, 鈴木明夫, 金物壽久, 浦野房三, 鈴木貞博, 松田正之, 加藤博之 : 関節リウマチの生物学的製剤治療における医療連携上の問題点. 中部リウマチ（2010）40, 86-87.
6) 小林 彩, 吉川美香, 小川英作, 奥山隆平 : 長野県における乾癬治療の現状と病診連携の可能性. 西日本皮膚科（2013）75, 346-349.